Results for tag: "Brain Injury Drug"

The Brain Injury Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. These drugs are used to treat a variety of conditions, including traumatic brain injury, stroke, Alzheimer's disease, Parkinson's disease, and epilepsy. Brain Injury Drugs are designed to reduce the severity of brain injury and improve the patient's quality of life. They can also be used to reduce the risk of further injury and improve cognitive function. Commonly used drugs in this market include anticonvulsants, anti-inflammatory drugs, and neuroprotective agents. Some companies in the Brain Injury Drug market include AbbVie, AstraZeneca, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more